Cargando…
From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson's disease?
Parkinson's disease is the second most prevalent neurodegenerative disorder worldwide. Clinically, it is characterized by severe motor complications caused by progressive degeneration of dopaminergic neurons. Current treatment is focused on mitigating the symptoms through the administration of...
Autores principales: | Silva, Rita Caridade, Domingues, Helena Sofia, Salgado, António J., Teixeira, Fábio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552835/ https://www.ncbi.nlm.nih.gov/pubmed/34558504 http://dx.doi.org/10.4103/1673-5374.324827 |
Ejemplares similares
-
N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model
por: Caridade-Silva, Rita, et al.
Publicado: (2023) -
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022) -
Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
por: Vilaça-Faria, Helena, et al.
Publicado: (2019) -
microRNA Fine-Tuning of the Germinal Center Response
por: Fuertes, Teresa, et al.
Publicado: (2021) -
Hybrid Fine-Tuning Strategy for Few-Shot Classification
por: Zhao, Lei, et al.
Publicado: (2022)